Skip to main content

Table 2 Correlation coefficients between LFC with demographic and laboratory parameters

From: Association of [1H]-MRS quantified liver fat content with glucose metabolism status

Parameters

nT2DM

(n = 141)

PDM

(n = 48)

Normal Control

(n = 53)

r

p

r

p

r

p

Age

− 0.024

0.781

0.072

0.626

0.151

0.280

BMI

0.268

0.001

0.416

0.003

0.223

0.108

WHR

0.314

0.000

0.183

0.214

0.107

0.446

SBP

0.190

0.024

0.256

0.079

0.223

0.109

DBP

0.178

0.035

0.074

0.616

0.114

0.414

FPG

0.222

0.008

0.385

0.007

0.398

0.003

2hPG

0.096

0.258

0.110

0.458

0.094

0.505

Urea Nitrogen

− 0.042

0.617

0.227

0.121

0.439

0.001

Cr

− 0.071

0.403

0.215

0.142

0.036

0.800

UA

0.121

0.151

0.390

0.006

0.178

0.203

TBIL

− 0.244

0.004

0.022

0.880

− 0.186

0.183

DBIL

− 0.213

0.011

0.099

0.502

− 0.267

0.053

IBIL

− 0.225

0.007

0.005

0.974

− 0.040

0.774

ALT

0.119

0.161

− 0.030

0.840

0.304

0.027

AST

0.060

0.483

0.038

0.800

0.140

0.316

GGT

0.014

0.867

0.122

0.408

0.135

0.336

ALP

0.038

0.653

− 0.009

0.951

0.291

0.035

LDH

0.062

0.469

− 0.033

0.823

0.015

0.915

TG

− 0.059

0.486

− 0.109

0.461

0.195

0.162

TC

− 0.042

0.621

− 0.056

0.705

0.186

0.182

HDL-C

− 0.038

0.657

− 0.157

0.286

− 0.262

0.058

LDL-C

− 0.008

0.922

− 0.041

0.780

0.192

0.169

VLDL-C

0.119

0.161

− 0.077

0.602

0.219

0.116

ApoB

− 0.112

0.185

− 0.163

0.267

0.023

0.868

ApoA1

− 0.008

0.922

− 0.193

0.189

− 0.289

0.036

HOMA-IR

0.262

0.002

0.400

0.005

0.274

0.047

HOMA-β

− 0.014

0.873

− 0.073

0.621

− 0.221

0.112

Matsuda ISI

− 0.149

0.078

− 0.056

0.706

− 0.234

0.092

  1. ApoA1 Apolipoprotein A1, ApoB Apolipoprotein B, ALP alkaline phosphatase, AST aspartate aminotransferase, ALT alanine transaminase, BMI body mass index, Cr creatine, DBIL direct bilirubin, DBP diastolic blood pressure, FPG fasting plasma glucose, GGT γ-glutamyltransferase, HOMA-IR homeostatic model assessment of insulin resistance, HOMA-β homeostatic model assessment for β-cell function, HDL-C high-density lipoprotein cholesterol, IBIL indirect bilirubin, LFC liver fat content, LDH lactate dehydrogenase, LDL-C low-density lipoprotein cholesterol, nT2DM newly diagnosed type 2 diabetes mellitus, NC normal control, PDM prediabetes mellitus, SBP systolic blood pressure, TC total cholesterol, TG triglycerides, TBIL total bilirubin, UA uric acid, VLDL-C very low-density lipoprotein cholesterol, WC waist circumference, WHR waist-to-hip ratio